Quick Answer
ALX ONCOLOGY HOLDINGS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2022.
- This data is from ALX ONCOLOGY HOLDINGS INC's annual report (Form 10-K), filed with the SEC on March 9, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2018 to 2022), ALX ONCOLOGY HOLDINGS INC's Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
- Historical annual values: Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $1.18 million | Fiscal year 2019: $4.80 million | Fiscal year 2018: $2.07 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: